Beating both EPS and sales estimates significantly, especially in a competitive sector like animal health, indicates strong operational performance and market confidence. This outperformance, particularly the growth in sales compared to the same period last year, is likely to positively influence investor sentiment and potentially lead to a short-term uptick in PAHC's stock price.